Skip to main content
. 2024 Nov 26;2024(11):CD013707. doi: 10.1002/14651858.CD013707.pub2

1.11. Analysis.

1.11

Comparison 1: Pairwise analysis: levosimendan versus milrinone, Outcome 11: Renal failure requiring replacement therapy